ROCKVILLE, Md.--(BUSINESS WIRE)--Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, announced today that the Company will participate in the 2011 UBS Global Life Sciences Conference, to be held September 19 - 21, 2011 in New York City. Christian Itin, Ph.D., Micromet’s President and Chief Executive Officer will present a 30 minute corporate overview on September 20th at 4:30 PM ET.
